News & Blog

Jumpstarting Brain Tumor Drug Development

National Brain Tumor Society staff and advisors recently met with the U.S. Food and Drug Administration (FDA) to discuss how various stakeholders in brain tumor drug development could work together to increase the volume and speed of approvals for new treatments for this disease.

A Response to the Results of Avastin Clinical Trials

National Brain Tumor Society comments on the recently announced results of the AVAglio and RTOG clinical trials.

Share